Mirimac Fund Inc
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, known for its sale of ONIVYDE to Ipsen S.A. in April 2017, which entitles them to contingent milestone payments. The company does not engage in ongoing research or development activities and operates without any employees, relying on external consultants for its operations.
Located at One Broadway, 14th floor in Cambridge, MA, Merrimack Pharmaceuticals focuses on managing its business through corporate governance structures, including a Board of Directors and Committee Composition. Investors can access stock information, press releases, events, presentations, SEC filings, and investor FAQs through the company's Investor Relations contact.
Generated from the website

